Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of NKTR by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−17,092−100.0%Sold outConverted for a 1-for-15 splitHolders
Q1 2025256,385$174.0K<0.1%00.0%UnchangedHolders
Q4 2024256,385$238.0K<0.1%00.0%UnchangedHolders
Q3 2024256,385$333.0K<0.1%00.0%UnchangedHolders
Q2 2024256,385$318.0K<0.1%00.0%UnchangedHolders
Q1 2024256,385$240.0K<0.1%00.0%UnchangedHolders
Q4 2023256,385$145.0K<0.1%00.0%UnchangedHolders
Q3 2023256,385$153.0K<0.1%00.0%UnchangedHolders
Q2 2023256,385$147.0K<0.1%00.0%UnchangedHolders
Q1 2023256,385$180.0K<0.1%00.0%UnchangedHolders
Q4 2022256,385$579.0K<0.1%−2,556−1.0%ReducedHolders
Q3 2022258,941$841.0K<0.1%−3,908−1.5%ReducedHolders
Q2 2022262,849$999.0K<0.1%00.0%UnchangedHolders
Q1 2022262,849$1.42M<0.1%−2,094−0.8%ReducedHolders
Q4 2021264,943$3.58M<0.1%00.0%UnchangedHolders
Q3 2021264,943$4.76M<0.1%−2,661−1.0%ReducedHolders
Q2 2021267,604$4.59M<0.1%+3,655+1.4%AddedHolders
Q1 2021263,949$5.28M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.